Lifeline Biotechnologies, Inc. (LLBO)
OTCMKTS · Delayed Price · Currency is USD
0.0003
-0.0002 (-40.00%)
Aug 20, 2025, 1:54 PM EDT
Lifeline Biotechnologies Market Cap
Lifeline Biotechnologies has a market cap or net worth of $2.17 million as of August 20, 2025. Its market cap has increased by 224.65% in one year.
Market Cap
2.17M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 2.17M, a decrease of -88.54%. That is a compound annual growth rate of -9.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 2.17M | 400.00% |
| Dec 31, 2024 | 434.89K | -35.07% |
| Dec 28, 2023 | 669.78K | -33.33% |
| Dec 30, 2022 | 1.00M | 50.00% |
| Dec 31, 2021 | 669.78K | -60.00% |
| Dec 31, 2020 | 1.67M | -37.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 614.68M |
| Glass House Brands | 567.91M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 375.77M |
| CytoDyn | 360.07M |